BioNTech SE (BNTX) Revenue (2018 - 2026)

BioNTech SE has disclosed Revenue across 9 years of filings, most recently posting $122.7 million for Q2 2026.

• In Q2 2026, Revenue fell 58.42% year-over-year to $122.7 million; the TTM figure through Jun 2026 stood at $3.1 billion (down 1.06% YoY), while the FY2025 annual figure was $3.3 billion, up 13.64% from the prior year.
• Revenue came in at $122.7 million for Q2 2026 at BioNTech SE, down from $138.3 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $7.2 billion in Q1 2022 to a low of $122.7 million in Q2 2026.
• Average Revenue over 5 years is $1.6 billion, with a median of $1.2 billion recorded in 2024.
• Year-over-year, Revenue surged 189.55% in 2022 and sank 94.65% in 2023.
• Over 5 years, Revenue stood at $4.4 billion in 2022, then plunged by 63.54% to $1.6 billion in 2023, then retreated by 20.09% to $1.3 billion in 2024, then retreated by 16.94% to $1.1 billion in 2025, then sank by 88.38% to $122.7 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $122.7 million in Q2 2026, $138.3 million in Q1 2026, and $1.1 billion in Q4 2025.